The expression landscape and heterogeneity of nectin-4, HER2, and Trop-2 in urothelial carcinoma: clinicopathological correlations and implications for ADC-guided precision therapy - Top-Institutions - MDSpire

The expression landscape and heterogeneity of nectin-4, HER2, and Trop-2 in urothelial carcinoma: clinicopathological correlations and implications for ADC-guided precision therapy

  • By

  • Shaobo Qin

  • Zhicheng Dai

  • Zhenxing Hu

  • Xiaohui Wang

  • Huiyan Zhang

  • Haotian Yang

  • Jie Liu

  • Lianghong Ma

  • July 8, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Linyi People’s Hospital
    Linyi People’s Hospital

    Linyi, Shandong

    Key Differentiators

    • Oncology

  • #2

    international UTUC collaboration
    international UTUC collaboration

    N/A, N/A

    Key Differentiators

    • Oncology

  • #3

    University of California Irvine
    University of California Irvine

    Irvine, California

    Key Differentiators

    • Oncology

Original Source(s)

The expression landscape and heterogeneity of nectin-4, HER2, and Trop-2 in urothelial carcinoma: clinicopathological correlations and implications for ADC-guided precision therapy

  • by Shaobo Qin, Zhicheng Dai, Zhenxing Hu, Xiaohui Wang, Huiyan Zhang, Haotian Yang, Jie Liu, Lianghong Ma

  • July 8, 2026

Related Content

Safety and efficacy of DLL3 CAR-T cells armored with dnTGFBR2 in a subject with recurrent small-cell lung cancer: case report

Clinical response to FGFR inhibitors in patients with FGFR2-amplified advanced gastric cancer: two case reports

Developing a predictive model for early urinary incontinence after laparoscopic radical prostatectomy: a retrospective cohort study